Therapeutic potential of sunitinib in the treatment of malignant islet cell tumor / 中华内分泌代谢杂志
Chinese Journal of Endocrinology and Metabolism
; (12): 618-620, 2011.
Artigo
em Chinês
| WPRIM (Pacífico Ocidental)
| ID: wpr-415369
Biblioteca responsável:
WPRO
ABSTRACT
Malignant islet cell tumor, a rare type of neuroendocrine carcinoma, biologically behaves in an aggressive way and is difficulty to be treated. Sunitinib malate, a novel tyrosine kinase inhibitor, demonstrates a high efficacy in treating malignant islet cell tumor as shown by promising results in recent trials.
Texto completo:
Disponível
Base de dados:
WPRIM (Pacífico Ocidental)
Idioma:
Chinês
Revista:
Chinese Journal of Endocrinology and Metabolism
Ano de publicação:
2011
Tipo de documento:
Artigo